BR

Brazil

11519 clinical trials

Find Trials

Clinical Trials (11519)

Showing 20 of 11,519 trialsScroll for more
NCT05242484Phase 216 sites

A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Active Not Recruiting
NCT06741969Phase 313 sites

Nipocalimab in Moderate to Severe Sjogren's Disease

Active Not Recruiting
NCT07196748Phase 321 sites

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Recruiting
NCT07058077Phase 23 sites

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

Recruiting
NCT06677060Phase 323 sites

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Recruiting
NCT07573176Phase 31 site

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Recruiting
NCT05568095Phase 34 sites

A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body

Active Not Recruiting
NCT04770753Phase 36 sites

A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)

Active Not Recruiting
NCT05488314Phase 19 sites

A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer

Active Not Recruiting
NCT06991114Phase 26 sites

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Recruiting
NCT06807424Phase 36 sites

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

Recruiting
NCT04770779Phase 32 sites

A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)

Active Not Recruiting
NCT02960022Phase 27 sites

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Recruiting
NCT07088926Phase 211 sites

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Recruiting
NCT05889182Phase 37 sites

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Recruiting
NCT05884398Phase 37 sites

A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC

Active Not Recruiting
NCT04892173Phase 316 sites

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Recruiting
NCT06365021Not Applicable1 site

ACT for Syndromic and Subsyndromic Depression in Bipolar Disorder

Completed
NCT06120140Phase 211 sites

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Active Not Recruiting
NCT06559306Phase 312 sites

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Recruiting